Healthcare provider profile · identity verified

William Hugh Phillips, MD

Family Practice · SPOKANE, WA · NPI 1952399115

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	364	53
Atorvastatin Calcium	Atorvastatin Calcium	271	81
Lisinopril	Lisinopril	262	77
Levothyroxine Sodium	Levothyroxine Sodium	253	71
Omeprazole	Omeprazole	205	62
Losartan Potassium	Losartan Potassium	177	52
Albuterol Sulfate Hfa	Albuterol Sulfate	174	55
Amlodipine Besylate	Amlodipine Besylate	152	42
Trazodone Hcl	Trazodone Hcl	139	43
Gabapentin	Gabapentin	134	41
Rosuvastatin Calcium	Rosuvastatin Calcium	126	43
Simvastatin	Simvastatin	126	36
Metoprolol Succinate	Metoprolol Succinate	119	36
Tamsulosin Hcl	Tamsulosin Hcl	114	35
Hydrochlorothiazide	Hydrochlorothiazide	102	27
Metformin Hcl Er	Metformin Hcl	98	30
Furosemide	Furosemide	90	29
Pantoprazole Sodium	Pantoprazole Sodium	89	32
Famotidine	Famotidine	85	29
Oxycodone Hcl	Oxycodone Hcl	85	suppressed
Sertraline Hcl	Sertraline Hcl	72	16
Bupropion Xl	Bupropion Hcl	71	20
Potassium Chloride	Potassium Chloride	70	27
Pregabalin	Pregabalin	69	13
Zolpidem Tartrate	Zolpidem Tartrate	67	13
Jardiance	Empagliflozin	65	20
Allopurinol	Allopurinol	64	17
Meloxicam	Meloxicam	62	21
Carvedilol	Carvedilol	60	20
Duloxetine Hcl	Duloxetine Hcl	60	22
Escitalopram Oxalate	Escitalopram Oxalate	60	21
Alprazolam	Alprazolam	54	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	52	11
Lorazepam	Lorazepam	49	14
Alendronate Sodium	Alendronate Sodium	47	13
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	47	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	47	12
Metoprolol Tartrate	Metoprolol Tartrate	45	13
Alvesco	Ciclesonide	44	14
Glipizide Er	Glipizide	44	12
Metformin Hcl	Metformin Hcl	44	13
Ondansetron Odt	Ondansetron	44	12
Doxepin Hcl	Doxepin Hcl	41	suppressed
Montelukast Sodium	Montelukast Sodium	41	13
Tizanidine Hcl	Tizanidine Hcl	39	14
Estradiol	Estradiol	36	suppressed
Fluticasone Propionate	Fluticasone Propionate	35	13
Hydroxyzine Hcl	Hydroxyzine Hcl	35	14
Ezetimibe	Ezetimibe	34	11
Prednisone	Prednisone	34	20
Spironolactone	Spironolactone	34	11
Fluoxetine Hcl	Fluoxetine Hcl	33	11
Venlafaxine Hcl Er	Venlafaxine Hcl	33	suppressed
Breyna	Budesonide/Formoterol Fumarate	32	suppressed
Buspirone Hcl	Buspirone Hcl	32	12
Atenolol	Atenolol	31	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	31	suppressed
Paroxetine Hcl	Paroxetine Hcl	31	suppressed
Clopidogrel	Clopidogrel Bisulfate	30	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	30	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	30	suppressed
Acyclovir	Acyclovir	29	suppressed
Torsemide	Torsemide	29	suppressed
Baclofen	Baclofen	27	suppressed
Lamotrigine	Lamotrigine	26	suppressed
Mirtazapine	Mirtazapine	26	11
Finasteride	Finasteride	24	suppressed
Oxycontin	Oxycodone Hcl	24	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	23	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	23	suppressed
Citalopram Hbr	Citalopram Hydrobromide	22	11
Glipizide	Glipizide	22	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	22	21
Triamcinolone Acetonide	Triamcinolone Acetonide	22	15
Diazepam	Diazepam	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	19	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	19	suppressed
Ibuprofen	Ibuprofen	19	suppressed
Methocarbamol	Methocarbamol	19	suppressed
Nitroglycerin	Nitroglycerin	18	15
Pravastatin Sodium	Pravastatin Sodium	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Spiriva Respimat	Tiotropium Bromide	18	suppressed
Topiramate	Topiramate	18	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	18	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	18	suppressed
Clonazepam	Clonazepam	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Prazosin Hcl	Prazosin Hcl	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	16	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	15	15
Amoxicillin	Amoxicillin	15	12
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	11
Hydromorphone Er	Hydromorphone Hcl	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Tramadol Hcl	Tramadol Hcl	15	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	suppressed
Cefdinir	Cefdinir	13	11
Fenofibrate	Fenofibrate	13	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Ozempic	Semaglutide	12	suppressed
Azithromycin	Azithromycin	11	11
Ketoconazole	Ketoconazole	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error